Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

Argenx Stock Extends Rally In A Base As Earnings Loom

Argenx stock is rising Wednesday as the major indexes sell off. The autoimmune disease treatment stock is climbing in an early-stage base.

Investors Business Daily

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Medical Daily

BridgeBio Breaks Out After Pfizer-Rivaling Heart Drug Obliterates Sales Expectations

BridgeBio stock broke out Wednesday after its new heart drug, a rival to Pfizer's blockbuster Vyndaqel, smashed sales expectations.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

You might soon be able to get Wegovy from an online shop — here is where you need to visit

The move comes as Danish drugmaker Novo Nordisk has acted to slash the popular weight loss drug’s price

The Independent UK

AstraZeneca Moves Some Production To US Amid Tariff Threat

British pharmaceutical giant AstraZeneca announced Tuesday that it has begun moving some of its European production to the United States, ahead of President Donald Trump's possible tariffs on the sector.

International Business Times

Drugmaker AstraZeneca shifts more production to US amid Trump tariffs

UK and rest of Europe risk losing out to US and China unless they ramp up spending on new medicines, says CEO Pascal Soriot

The Guardian - UK

CG Oncology Soars On Its Johnson & Johnson-Rivaling Cancer Drug

Shares of CG Oncology catapulted Monday after the biotech unveiled promising results for a J&J-rivaling bladder cancer treatment.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Bayer Says Legal Woes Could Force It To Pull Weedkiller

German chemicals giant Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

International Business Times

Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock.

Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.

Investors Business Daily

Will This Cancer Stock Buck Trump's Tariff Onslaught As It Nears Buy Point, Earnings?

BeiGene stock has formed an early-stage base with a buy point of 287.88 ahead of its first-quarter results on May 7.

Investors Business Daily

US drug firm Merck says existing Trump tariffs will cost it $200m this year

Company’s forecast does not account for threatened ‘major’ tariff that could also be levied on pharmaceutical imports

The Guardian - UK

Merck Stock Reverses, Though Gardasil 'Woes' Continue In China, Japan

Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, Gardasil.

Investors Business Daily

BioNTech Surges On Summit's Coattails. But Can They Take On Merck?

BioNTech stock rocketed Wednesday after rival Summit Therapeutics unveiled promising results for a novel approach to lung cancer treatment.

Investors Business Daily

Stroke Management Drug Firm Climbs To Key Level Ahead Of Earnings; But Beware This Pharma Tariff

Penumbra stock is holding the 50-day moving average in a base ahead of earnings on Wednesday.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

Investors Business Daily

Immunovant Dives On Its C-Suite Sweep, Narrowed Plans For Leading Drug

Roivant Sciences is making serious changes to subsidiary Immunovant, announcing Monday a series of C-suite changes and new disease targets.

The Independent UK

More pharmacies offer to speed prescription deliveries to customers

America’s two largest retailers want to deliver prescriptions to your doorstep, sometimes in a matter of hours

The Guardian - UK

Ministers in ‘active conversation’ with UK drug firms over potential tariffs

Government seeks ways to shield industry from possible US levies amid concern over effect on medicine supply

Get all your
news in one place.

100’s of premium titles.
One news app.

International Business Times

Leadership Through Kelli Rodriguez's Lens: Diversity, Communication, & Women's Empowerment

For more than 20 years, Rodriguez has played an instrumental role in launching, restructuring, and scaling global and domestic brands, cementing her reputation as an industry leader.

International Business Times

Trump Tariffs Unnerve Locals In Irish 'Pharma' Hub

Vast pharmaceutical factories pepper the green landscape in southern Ireland, but the wind turbines next to the plants outside Cork are in the eye of Donald Trump's global trade storm.

Investors Business Daily

Argenx Bounds Off 200-Day Line On 'Best-Case Scenario' For Blockbuster Drug

Argenx stock jumped Friday after the FDA cleared its autoimmune disease drug, Vyvgart Hytrulo, for at-home treatment.

Latin Times

Novartis Plans $23 Billion US Buildout as Pharma Faces Pressure From Trump

Novartis plans a $23 billion U.S. expansion to boost drug production and counter potential import tariffs.

Investors Business Daily

IBD 50 Stock Flashes 'Golden Cross' But Massive Risk Looms

Ani Pharmaceuticals stock is near a buy point in a cup-with-handle base after flashing a "golden cross" signal.

Investors Business Daily

S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash

Pharma stocks tumbled Thursday after the Trump administration said the delay for reciprocal tariffs doesn't apply to sector-specific tariffs.

Investors Business Daily

This Medical Supplies Distributor Dodges A Tariff Bullet

This medical supplies distributor stock is off a recent high and back in a buy zone.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Investor Business Daily

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.